Featured Research

from universities, journals, and other organizations

Is photoscreening the best way to catch 'lazy eye'?

Date:
October 1, 2010
Source:
American Academy of Ophthalmology
Summary:
Amblyopia, known as "lazy eye," is a major cause of vision problems in children and a common cause of blindness in people aged 20 to 70 in developed countries. Pediatric ophthalmologists are looking for the best, most cost-effective ways to detect amblyopia as early as possible. Iowa's KidSight program, the largest, longest study of the use of photoscreening to detect amblyopia in children aged 6 months to 6 years.

Amblyopia, known as "lazy eye," is a major cause of vision problems in children and a common cause of blindness in people aged 20 to 70 in developed countries. In amblyopia the person's stronger eye is favored and his/her weaker eye gradually loses visual power as a result. When the condition is detected and treated before age 7, more than 75 percent of children achieve 20/30 vision or better, the Amblyopia Treatment Study reports. But parents and teachers can easily miss this problem-especially in very young children.

Pediatric ophthalmologists (Eye M.D.s), pediatricians, family doctors and educators are looking for the best, most cost-effective ways to detect amblyopia as early as possible October's Ophthalmology journal reports on Iowa's KidSight program, the largest, longest study of the use of photoscreening to detect amblyopia in children aged 6 months to 6 years.

More than 147,000 children were screened between 2000 and 2009 in this collaboration of the KidSight program, medical director William E. Scott, MD, of the University of Iowa, Department of Ophthalmology and Visual Sciences, and the Iowa Lions Clubs. Photoscreening technology was used because earlier studies indicated problems with using eye charts to screen children younger than age 3 and children with disabilities. This study used the Medical Technology, Inc. (MTI) PhotoScreener, which records the pattern of light reflected through each of the child's pupils as the child's eyes are photographed. Other studies of normal and high-risk children found the MTI effective for screening for amblyopic risk factors, which include: unequal visual acuity between the two eyes (anisometropia), high nearsightedness, high farsightedness, astigmatism, and strabismus (eye turned inward or outward).

Trained Lions Club volunteers conducted the free screenings at state-registered childcare centers, Head Start Programs, and state-sponsored clinics, as well as libraries, churches and children's fairs. Photoscreened images were then assessed by a trained reader (the same person throughout the study) at the University of Iowa, and children with abnormal results were referred to ophthalmologists or optometrists for thorough eye exams. A part-time coordinator worked with parents to ensure that referred children kept their follow-up appointments.

About 4 percent of children screened needed follow-up for possible amblyopia, which corresponds to the expected rate of the disorder in the general population. More than 95 percent of the nearly 148,000 children in the study received a reliable screening result, and follow-up was successful for more than 80 percent of those referred for further testing.

"This program has had a lasting, beneficial impact on the children of Iowa, and seems to be cost-effective as well," Dr. Scott said. "Here's what made it successful: a ready supply of volunteers who were easily trained to screen large numbers of children at low cost; an appropriate, sensitive, reliable screening method (photoscreening) that required little training; quality control methods; referral relationships with eye care professionals; and effective follow-up with referred families."

Amblyopia is usually treated with special eyeglasses, patching of the stronger eye, medications, or a combination of approaches.


Story Source:

The above story is based on materials provided by American Academy of Ophthalmology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Ophthalmology. "Is photoscreening the best way to catch 'lazy eye'?." ScienceDaily. ScienceDaily, 1 October 2010. <www.sciencedaily.com/releases/2010/10/101001105154.htm>.
American Academy of Ophthalmology. (2010, October 1). Is photoscreening the best way to catch 'lazy eye'?. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/10/101001105154.htm
American Academy of Ophthalmology. "Is photoscreening the best way to catch 'lazy eye'?." ScienceDaily. www.sciencedaily.com/releases/2010/10/101001105154.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins